In 2015, ENSCCA (European Network for the Study of Cholangiocarcinoma) was founded with the aim of creating a pan-European interdisciplinary cooperative network to address the problem of cholangiocarcinoma (CCA) at the basic, translational and clinical levels. Its first initiative was the creation of the ENSCCA Clinical Registry in 2016...
Read more...Posts Tagged: AMMF
- AMMF’s Hybrid 2023 European Cholangiocarcinoma Conference
- 2021 Conference Programme
- A step towards more effective treatments …
- ABC-07 (SBRT)
- ABC-09 (EORTC-1607-GITCG)
- About AMMF – The Cholangiocarcinoma Charity
- ACTICCA-1
- adidas Silverstone Half Marathon – Sunday 6th March, 2011
- Aintree University Hospital, Liverpool
- Alphabetical Photo Page
- Ambassadors
- Amble for AMMF – Keeping it Legal
- Amble for AMMF 2016
- AMMF 6-page leaflet
- AMMF BBC Devon TV Interview with Mark & Terry Matthews
- AMMF calls for a Fairer Deal, Faster in Westminster
- AMMF CCA Conference 2019 – Speakers
- AMMF CCA Conference 2019 – the event in images
- AMMF CCA Conference 2022 – the event in images
- AMMF Cholangiocarcinoma Conference 2017
- AMMF Cholangiocarcinoma Conference 2018
- AMMF Cholangiocarcinoma Conference 2018 – Speakers
- AMMF Cholangiocarcinoma Conference 2019
- AMMF European Cholangiocarcinoma Website
- AMMF fundraising activities
- AMMF Grants for Research
- AMMF Research Grants – Applications
- AMMF Shop
- AMMF Slimathon- Losing weight and Gaining Pounds for AMMF!
- AMMF Summer Ball 2010
- AMMF welcomes our Thai Delegation
- AMMF will be at Scottish Parliament to advocate for better care in cholangiocarcinoma
- AMMF’s Cholangiocarcinoma Conference 2019 Full details and FAQs
- AMMF’s Conference, Thursday 11 May 2017
- AMMF’s Conferences over the years …
- AMMF’s Discussion Groups
- AMMF’s Facebook Guest Posts 2017
- AMMF’s Hybrid 2022 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s position on the use of animals in research
- AMMF’s Top Fundraising Tips
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s White Paper is launched in Westminster
- An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
- Angiogram
- ARTEMIDE-Biliary01
- Asp-PSC – a study for those with primary sclerosing cholangitis (PSC)
- Basket
- Biomarker BI-010 looks promising …
- Biopsy
- Birmingham University
- CAF – Matched Giving and Give as you Earn Schemes (for employers and employees)
- Call for Abstracts
- Call for Abstracts 2025
- Cancer Research UK / The BILCAP Trial
- Causes and risk factors
- CC Day 1 – Guest Post from Helen Tanner
- CC Day 10 – Guest Post by Colette Valentine
- CC Day 11 – Tribute to Amanda Lofting
- CC Day 12 – Guest Post by Clare Henderson & Kirsty Mackay
- CC Day 13 – Guest Post by Sophie Culshaw
- CC Day 14 – Guest Post by Rachael Cornish
- CC Day 15 – Guest Post by Aleisha and Thomas Gray
- CC Day 16 – Guest Post by Claire Johnson
- CC Day 17 – Guest Post by Brian Russell
- CC Day 18 – Guest Post by Kaz Molloy
- CC Day 19 – Guest Post by Laura Flett
- CC Day 2 – Guest Post by Rebecca West
- CC Day 20 – Guest Post by Liam Crossley
- CC Day 21 – Guest Post by Karen Finlinson
- CC Day 22 – Guest Post by Bernie Podmore & Gerry Hatheralll
- CC Day 23 – Guest Post by Victoria Carney
- CC Day 24 – Guest Post by Andrea Sheardown
- CC Day 25 – Guest Post by Hedli Niklaus
- CC Day 26 – Guest Post by Nikki Greenall
- CC Day 27 – Guest Post by Amelia Andrews
- CC Day 28 – Guest Post by Beryl Jones
- CC Day 3 – Guest Post by Ben Francis
- CC Day 4 – Guest Post by Thomas Barker
- CC Day 5 – Guest Post by Vikki Stokes
- CC Day 6 – Guest Post by Shirley Turton
- CC Day 7 – Guest Post by Matthew Burns
- CC Day 8 – Guest Post by Claire Bradburn
- CC Day 9 – Guest Post by Natalie Meikle
- Checkout → Pay
- Cholangiocarcinoma Awareness Month
- Cholangiocarcinoma Awareness Month – February 2014
- Cholangiocarcinoma Awareness Month – February 2015
- Cholangiocarcinoma Awareness Month
My CCA Story - Cholangiocarcinoma Defined
- Choledochal cysts
- Collaboration & Cooperation
- Cookie Policy
- Corporate support
- Current Cholangiocarcinoma Trials
- Current trials no longer recruiting
- DETERMINE
- Diagnosis and Staging
- Disclaimer
- Discussion Forum
- Discussion forum Enquiries
- ERCP (endoscopic retrograde cholangiopancreatography)
- FIGHT-207
- FIGHT-302
- Forum Terms and Conditions
- Fundraising Enquiries
- General Enquiries
- Get Involved: Fundraise for AMMF and Make a Difference
- Giving in Memory
- GP Awareness Campaign 2025
- Grant for ICC Research
- Guidelines for the Diagnosis and Management of Cholangiocarcinoma
- Helpful Links on the topics of Dying and Bereavement
- Home
- Ignyta STARTRK-2
- Imperial College
- Imperial College London
- Imperial College London
- Imperial College London
- Imperial College London
- Inaugural CCA-UK Meeting, 07 December, 2018
- Info and FAQ’s
- Institute of Genetics & Molecular Medicine
- Institute of Hepatology
- Institute of Hepatology
- International Centres
- International patients requesting medical treatment in the UK
- Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Patients With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
- John’s Biomarker Award
- Laparoscopy
- Lastest News
- Latest Topics
- Leaving a Gift in your Will
- Logout
- Making a Will
- Medical/Clinical Advisors
- Meeting with CRUK re BILCAP
- Molecular Profiling and Targeted Therapies
- Molecular Profiling, Targeted Therapies and Immunotherapy – updates
- Molecular Profiling: booklet and video
- MRI (magnetic resonance imaging)
- My Account
- New Genetic Research
- News
- NuTide:121
- Nutrition
- Online shop Enquiries
- Order Received
- Other CChallenges …
- Other recent runs
- Other ways to get involved
- Our CCA Family
- Our CCA Family – Your Story
- Our Literature
- Palliative care
- Paris Marathon 2010
- Patient Guide in Biliary Tract Cancer
- Patient Information sheets
- Patient Organisation Cholangiocarcinoma Education Resources
- Patient Resources
- Patient Webinars
- PCI and Chemotherapy
- PET (positron emission tomography)
- photo
- Preparing for the death of a terminally ill loved one: What to expect
- Privacy Statement
- PTC (percutaneous transhepatic cholangiography)
- Questions to ask your Doctor
- Quiz Nights
- Radiotherapy
- Recently completed grants
- Referral information
- Reports
- Research Updates
- Rethink Liver Cancer 2024
- Rethink Liver Cancer 2025
- Rethink Liver Cancer in Scotland
- SAFIR ABC-10
- Scientific Advisors
- Second opinions and liver disease centres
- Sending or transferring funds to AMMF
- Speakers at AMMF’s Cholangiocarcinoma Conference 2017
- Specialist Viewpoint
- Specialist Viewpoint
- Specialist Viewpoint
Cholangiocarcinoma – An overview - Specialist Viewpoint
Cholangiocarcinoma – An overview - Specialist Viewpoint
Demystifying the MDT - Specialist Viewpoint
Pathology - Sponsorship opportunities are available
- Sporting events
- Staging
- Staging Cholangiocarcinoma
- Stent insertion
- Stop cholangiocarcinoma striking before it’s too late
- Surgery
- Surgery for Cholangiocarcinoma, and why it may not be possible
- Symptoms
- Take the CChallenge!
- Terry and Mark’s BBC interview
- Thank you
- The “Say it, Share it, Send it!” campaign
- The ABC-12 Study
- The BILCAP Trial
- The day in pictures
- The day unfolds
- The Faces of Cholangiocarcinoma 2025
- The SIRCCA Trial
- The TAS120-101 trial
- The University of Manchester
- The University of Oxford
- The Work of AMMF – An Overview
- Treatment options
- Trials in set up
- Trustees
- University College London
- University College London
- University of East Anglia
- University of Edinburgh
- University of Liverpool
- University of Nottingham
- Upcoming
- User Avatar
- Vacancies
- Virgin London Marathon – Sunday 22nd April 2012
- Virgin London Marathon 2010
- What is Cholangiocarcinoma?
- What is Cholangiocarcinoma?
- What you said
- World Cholangiocarcinoma Day
- Grants Made
- Donate to AMMF
- Helpful Links
- Introduction to Cholangiocarcinoma
- Contact Us
AMMF newsletter
Posted
Click here to download our latest Newsletter
Read more...
